We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Expanded Crestor Indication Recommended by Committee
Expanded Crestor Indication Recommended by Committee
December 18, 2009
An FDA advisory panel has recommended that the agency approve expanded use of AstraZeneca’s Crestor to prevent cardiovascular disease but urged patient
monitoring for signs of diabetes.